Invesco Ltd. Abeona Therapeutics Inc. Call Options Transaction History
Invesco Ltd.
- $600 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ABEO
# of Institutions
108Shares Held
32.9MCall Options Held
1.34MPut Options Held
271K-
Nantahala Capital Management, LLC New Canaan, CT4.56MShares$20.3 Million0.98% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.05MShares$13.6 Million0.03% of portfolio
-
Suvretta Capital Management, LLC New York, NY2.68MShares$11.9 Million0.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.6MShares$11.6 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA1.84MShares$8.2 Million1.55% of portfolio
About ABEONA THERAPEUTICS INC.
- Ticker ABEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,950,380
- Market Cap $26.5M
- Description
- Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...